"Biological Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Treatment of diseases with biological materials or biological response modifiers, such as the use of GENES; CELLS; TISSUES; organs; SERUM; VACCINES; and humoral agents.
Descriptor ID |
D001691
|
MeSH Number(s) |
E02.095
|
Concept/Terms |
Biological Therapy- Biological Therapy
- Biological Therapies
- Therapies, Biological
- Therapy, Biological
- Biologic Therapy
- Biologic Therapies
- Therapies, Biologic
- Therapy, Biologic
- Biotherapy
- Biotherapies
|
Below are MeSH descriptors whose meaning is more general than "Biological Therapy".
Below are MeSH descriptors whose meaning is more specific than "Biological Therapy".
This graph shows the total number of publications written about "Biological Therapy" by people in this website by year, and whether "Biological Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2002 | 1 | 0 | 1 |
2009 | 1 | 0 | 1 |
2010 | 1 | 0 | 1 |
2011 | 1 | 0 | 1 |
2013 | 0 | 1 | 1 |
2014 | 0 | 1 | 1 |
2015 | 0 | 1 | 1 |
2018 | 1 | 0 | 1 |
2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Biological Therapy" by people in Profiles.
-
Freedman KB. Editorial Commentary: Risks of Biologic Therapies in Sports Medicine: Landmines on the Road to the Holy Grail. Arthroscopy. 2021 08; 37(8):2606-2607.
-
Hadley CJ, Shi WJ, Murphy H, Tjoumakaris FP, Salvo JP, Freedman KB. The Clinical Evidence Behind Biologic Therapies Promoted at Annual Orthopaedic Meetings: A Systematic Review. Arthroscopy. 2019 01; 35(1):251-259.
-
Gaspari AA, Tyring S. New and emerging biologic therapies for moderate-to-severe plaque psoriasis: mechanistic rationales and recent clinical data for IL-17 and IL-23 inhibitors. Dermatol Ther. 2015 Jul-Aug; 28(4):179-93.
-
Tzeng A, Tzeng TH, Vasdev S, Korth K, Healey T, Parvizi J, Saleh KJ. Treating periprosthetic joint infections as biofilms: key diagnosis and management strategies. Diagn Microbiol Infect Dis. 2015 Mar; 81(3):192-200.
-
Ndao DH, Ladas EJ, Bao Y, Cheng B, Nees SN, Levine JM, Kelly KM. Use of complementary and alternative medicine among children, adolescent, and young adult cancer survivors: a survey study. J Pediatr Hematol Oncol. 2013 May; 35(4):281-8.
-
Kepler CK, Anderson DG, Tannoury C, Ponnappan RK. Intervertebral disk degeneration and emerging biologic treatments. J Am Acad Orthop Surg. 2011 Sep; 19(9):543-53.
-
Abboud JA. Current concepts in rotator cuff disease and treatment: editorial comment. Clin Orthop Relat Res. 2010 Jun; 468(6):1467-8.
-
Bremmer M, Deng A, Gaspari AA. A mechanism-based classification of dermatologic reactions to biologic agents used in the treatment of cutaneous disease: Part 1. Dermatitis. 2009 Jul-Aug; 20(4):182-92.
-
Herbst RS, Khuri FR, Lu C, Liu DD, Fossella FV, Glisson BS, Pisters KM, Shin DM, Papadimitrakopoulou VA, Kurie JM, Blumenschein G, Kies MS, Zinner R, Jung MS, Lu R, Lee JJ, Munden RF, Hong WK, Lee JS. The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapy. Cancer. 2002 Jul 15; 95(2):340-53.